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A B S T R A C T
Purpose: Predicting seizure control after epilepsy surgery is difﬁcult. The objectives of this work are: (a)
to estimate the value of surgical procedure, presence of neuroimaging abnormalities, need for
intracranial recordings, resection lobe, pathology, durations of epilepsy and follow-up period to predict
postsurgical seizure control after epilepsy surgery and (b) to provide empirical estimates of successful
outcome after different combinations of the above factors in order to aid clinicians in advising patients
presurgically about the likelihood of success under their patients’ individual circumstances.
Methods: We report postsurgical seizure control from all 243 patients who underwent resective surgery for
epilepsy at King’s College Hospital between 1999 and 2011. Among the 243 patients, 233 had lobar or sub-
lobar resections, 8 had multilobar resections and 2 had excision of a hypothalamic hamartoma. We examined
the relation between postsurgical seizure control and type of surgical procedure, presence of neuroimaging
abnormalities, pathology, resection lobe and the need of intra-cranial electrodes to identify seizure onset.
Results: Among the 243 patients, 126 (52%) enjoyed outcome grade I, 40 (16%) had grade II, 51 (21%) had
grade III and 26 (11%) had grade IV (mean follow-up 41.1 months). Normal neuroimaging or need for
intracranial recordings was not associated with poorer outcome. Patients undergoing temporal
resections showed better outcome than those with frontal resections, due to the poor outcome seen in
frontal patients with normal neuroimaging. Among temporal resections, there was no difference in
outcome between patients with and without neuroimaging abnormalities. Among patients with lesions
on imaging, temporal and frontal resections showed similar outcomes. Likelihood of favourable outcome
under the patient’s individual circumstances was estimated by the tables provided. There was an 8–9%
decrease in the percentage of grade I between follow-up at 12 and >36 months.
Conclusion: Overall, nearly 70% of patients undergoing resective surgery enjoy favourable post-surgical
seizure control. Normal neuroimaging should not discourage surgery in temporal patients but is a
negative prognostic sign in normal MRI frontal patients. There were no statistical differences in outcome
between patients with neuroimaging lesions in frontal or temporal lobes.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is one of the most common neurological disorders
affecting approximately 50 million people worldwide.1 Medical
treatment is the ﬁrst choice for the treatment of epilepsy. However,
seizures remain uncontrolled by medication in approximately 40%
of patients with focal epilepsy.2 Patients with symptomatic
epilepsy uncontrolled by medication may beneﬁt from surgicalvier Ltd. All rights reserved.
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type, location and extension of the underlying pathology, and its
relation to functionally relevant cortex. A variety of methods are
available for the identiﬁcation of seizure focus, including interictal
and ictal scalp electroencephalography,3–5 magnetic resonance,6
positron emission tomography7 and neuropsychology.8 However,
approximately 25–30% of patients operated in the best centres do
not improve substantially after surgery.9,10 The reasons for surgical
failure are unclear. Presurgical identiﬁcation of patients who will
suffer poor outcome is difﬁcult even with the use of modern
neuroimaging and intracranial electroencephalography. In prac-
tice, the surgical decision depends on presurgical estimations of
the likelihood of patients’ improving with surgery.
A number of pre-operative predictive factors for seizure control
after epilepsy surgery have been described. Positive prognostic
factors (those associated with better post-surgical seizure control)
include the extent of surgical resection, presence of unilateral
lesions on MRI,11–15 convulsive seizures,16–19 localised spikes and
EEG onset12,16,20–22; mesial temporal sclerosis,20,23 history of
febrile seizures,22 EEG/MRI concordance, focal and tumour
pathology,21,24–27 removal of regions showing abnormal responses
to single pulse electrical stimulation in intracranial recordings,28,29
abolition of seizure-like interictal discharges in focal cortical
dysplasia,30 concordance of multiple tests12,13,31–33 and the nature
of the surgical procedure, with temporal lobectomy and hemi-
spherectomy resulting in better seizure control.34 Negative
prognostic factors (those associated with poor post-surgical
seizure control) include extratemporal epilepsy,35,36 the need for
intracranial monitoring in complex epilepsies18,24,25 long history
of epilepsy17,18,27,37 and, for long-term seizure control, performing
a temporal neocorticectomy.38 Contradictory results have been
reported with regard to the prognostic value of normal neuroim-
aging.9,11–13,27,37,39 Many of these studies rely on relatively small
number of patients or on meta-analyses from literature reviews
from multiple centres with differing inclusion criteria, assessment
methods and surgical procedures. Consequently, separate studies
often identify different prognostic factors without necessarily
validating those reported by others, occasionally yielding contra-
dictory results.
Some of these inconsistencies may be resolved by the study of a
large patient series from a single centre with uniform criteria.
Essentially, prognostic factors are identiﬁed by comparing the
proportion of patients showing favourable outcome under differ-
ent conditions. Whereas this provides a good idea of behaviour of
the patient sub-populations relative to each other, it may not be
helpful in the discussion of individual cases because a large
proportion of patients can have favourable outcome even in the
presence of negative prognostic factors, and vice versa. In the
present work, in addition to the standard approach of reporting
prognostic factors, we provide tables with an estimation of the
proportion of patients showing favourable surgical outcome
according to their speciﬁc circumstances with regard to neuroim-
aging ﬁndings, pathology, need for intracranial recordings and
resection lobe. This can help the clinician to discuss surgical
options with individual patients by ﬁnding the proportion of
patients who enjoyed favourable outcome among the subgroup of
patients who share their speciﬁc circumstances. We report
presurgical ﬁndings and seizure outcome from all 243 patients
who underwent resective surgery for epilepsy at King’s College
Hospital between 1999 and 2011, and examined if there is a
relation between postsurgical seizure control and presence of
neuroimaging abnormalities, pathology, resection lobe, the need of
intra-cranial electrodes to identify seizure onset, and the durations
of the follow-up period and of the epilepsy at the time of surgery.
We report the proportion of patients who improved under
different combinations of the above factors in order to aidclinicians in advising patients presurgically about the likelihood
of success under their individual circumstances. Although strictly
speaking, pathology is not a pre-surgical ﬁnding, we report it here
because the pathological nature of the underlying lesion can be




The inclusion criterion was to have undergone resective-only
surgical procedures for epilepsy by two neurosurgeons (RPS or
CEP) during a 12 year period, between 1st January 1999 and
5th January 2011. This included a total of 243 patients. Over the 12-
year period, patients were treated by two neurosurgeons and
assessed by four neurophysiologists.
In patients assessed using chronically implanted intracranial
electrodes, the type, number, and position of the electrodes were
determined by the location of the suspected epileptogenic zone in
each patient, according to ﬁndings from clinical history, neuroim-
aging, neuropsychology, scalp electroencephalographic recordings,
and videotelemetry with electrode application according to the
Maudsley System.40,41 The selection criteria for intracranial
recordings and implantation procedure have been described
elsewhere42 and are summarised below. All patients with normal
neuroimaging were assessed with intracranial electrodes. Used
electrodes were disposed of to prevent transmission of Creutzfeld–
Jacob disease. Prophylactic antibiotics were prescribed (intravenous
cefuroxime, 750 mg three times daily) during the period of recording
with intracranial electrodes to minimise the risk of infection.
Resections were guided by preoperative subacute intracranial
recordings or intraoperative electrocorticography and by intra-
operative image guidance (Stealth, Medtronic, Houston, TX, USA).
Under UK regulations, no NHS Research Ethics Committee
approval was required under section 6 of the Governance
Arrangements for Research Ethics Committees (September 2011).
This study has been approved by the Neuroscience Audit Committee
at King’s College Hospital.
2.2. Indications for implantation of intracranial electrodes
The following two patient groups had surgery without studies
with intracranial electrodes:
 Lesionectomy—Patients with a discrete cerebral lesion demon-
strated by neuroimaging at a non-functionally eloquent site,
with location concordant with seizure semiology, topography of
interictal discharges, topography of ictal onset on the scalp EEG if
known, distribution of background abnormalities in the interictal
EEG, and neuropsychological ﬁndings.
 Temporal lobectomy—Patients with a lesion on neuroimaging that
can be removed by a standard temporal lobectomy and that is
consistent with a single temporal site of seizure onset on scalp
EEG telemetry concordant with seizure semiology, distribution
of background abnormalities in the interictal scalp EEG, and
neuropsychological ﬁndings.
Patients not fulﬁlling these criteria had studies with intracra-
nial electrodes. These were patients in whom a hypothesis was
available to explain ﬁndings to date, particularly any non-
convergence of evidence from different tests, and this hypothesis
was testable with intracranial electrode implantation. The choice
and placement of intracranial electrodes depended on the working
hypothesis with regard to the site of seizure onset. As intracerebral
(depth) electrodes are perceived to be more invasive that subdural
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temporal lobe seizures were suspected but laterality was uncer-
tain, recordings with bilateral 8-contact subtemporal strips
inserted through frontotemporal burr holes were carried out. If
this procedure yielded inconclusive results, a second intracranial
recording was undertaken with bilateral temporal intracerebral
electrodes implanted using a lateral approach. When seizures
where thought to arise from the frontal lobes, but laterality was
uncertain, bilateral intracerebral electrodes were used. When the
seizures were thought to arise from the cerebral convexity, from
the paracentral lobule, or from the supplementary motor area,
mats or strips were used, usually implanted unilaterally, especially
if the presumed site of seizure onset was thought to lie close to
eloquent cortex.
Resective surgery was excluded in the following circumstances:
 The EEG showed predominantly generalised interictal EEG
discharges in the absence of a discrete lesion on neuroimaging.
 A site of seizure onset was identiﬁed which could not be resected
without unacceptable complications.
 Bilateral or multilobar seizure onset was seen with intracranial
recordings and there was no clear alternative hypothesis for
further studies with intracranial recordings.
2.3. Intracranial recordings
Subdural or intracerebral (depth) electrodes (supplied by AdTech
Medical Instruments, Wisconsin, USA) were implanted in all
patients assessed with intracranial electrodes. Subdural electrodes
were either strips or mats. Each strip consisted of a single row of 4–8
platinum disc electrodes spaced at 10 mm between centres. The
disks were embedded in a 0.7 mm thick polyurethane strip which
overlapped the edges, leaving a diameter of 2.3 mm exposed, and
recessed approximately 0.1 mm from the surface plane.
Mats contained rectangular arrays of 12, 16, 20, 32, or 64 similar
platinum electrodes. Intracerebral (depth) electrodes consisted of
multicontact ﬂexible bundles of electrodes, which were implanted
stereotactically under MRI guidance. The electrodes consisted of
six to 10 cylindrical 2.3 mm long platinum contacts separated by
5 mm between centres of adjacent electrodes of the same bundle.
Intracranial recordings lasted between 4 days and 3 weeks with
the aim of recording at least three seizures. They included
functional stimulation to identify motor, sensory or speech areas
when required and single pulse electrical stimulation.28,29
2.4. Neuroimaging
All patients had cerebral MRI with a 1.5 T magnet. The MRI
protocol included the following MRI sequences, which were used
in all patients1: coronal fast spin echo T2 weighted (time of echo
(TE) = 85 ms, time of repetition (TR) = 4300 ms), 3.5 mm slice
thickness, 0.5 mm gap, perpendicular to temporal horn2; coronal
FLAIR (ﬂuid attenuated inversion recovery) (TE = 115 ms,
TR = 8500 ms, inversion time (TI) = 1900 ms), 3.5 mm slice thick-
ness, 0.5 mm gap, perpendicular to temporal horn3; coronal
inversion recovery prepped spoiled gradient recalled (SPGR), T1
weighted, ﬂip angle 308, TE = 2.8 ms, TR = 14 ms, 1.5 mm parti-
tion4; axial fast spin echo T2 weighted (TE = 75 ms, TR = 3500 ms),
5 mm slice thickness, 2 mm gap, parallel to the line between
anterior and posterior commissures (AC–PC line). Hippocampal
volumetry was not used regularly, as it is not widely accepted as
routine clinical practice and visual assessment by experienced
radiologists appears to be almost as good in detecting hippocampal
atrophy.43 Unclear non-speciﬁc changes of dubious signiﬁcance
were not considered as lesions. Thus patients showing only such
changes were included in the group of normal neuroimaging. Inequivocal cases, images were reformatted on an Advantage
Windows workstation (GE Medical systems). Computed tomogra-
phy was not done routinely.
2.5. Surgical procedures
Surgery included temporal, frontal, parietal or occipital
resections. Tissue was removed and pathology studies performed.
En-bloc temporal lobectomies followed an anatomically standar-
dised surgical techniques.44 En bloc temporal lobectomy was
undertaken at the Maudsley and King’s College Hospitals as
originally described by Falconer,45 later modiﬁed to achieve a
more complete removal of the hippocampus by use of the
principles described by Spencer et al.46 In effect, between 5.5 cm
and 6.5 cm of temporal lobe was removed. In the dominant
hemisphere, usually the left, all superior temporal gyrus except
the anterior 2 cm was spared. Such a resection would have
included at least 50% of the amygdala and 2–3 cm of para-
hippocampal gyrus and hippocampus. The extent of the resection
was occasionally modiﬁed according to electrocorticographic
ﬁndings. Extratemporal resections were guided by electrocorti-
cographic recordings with the purpose of removing regions
showing pathological slowing, epileptiform discharges and their
leading regions.
2.6. Neuropathology
All resected specimens were ﬁxed in buffered formalin for
24–48 h and serially sliced at 0.5 cm interval. The slices were
processed to parafﬁn. In specimens with no macroscopic
abnormality, all the slices were processed. When a macroscopic
lesion was noted, blocks were taken from the lesion, from
regions adjacent to the lesion, and from the margins of the
specimen. Sections were stained with haematoxylin and eosin,
luxol fast blue/Nissl, and the silver impregnation method of
Glees and Marsland, and immunocytochemistry was carried out
by the ABC method for glial ﬁbrillary acidic protein (Dako,
Glostrup, DK, polyclonal, 1:1500) and neuroﬁlament 200KD (Dako,
Glostrup, DK, monoclonal, 1:500). Selected blocked were examined
by immunohistochemistry for antibodies against NeuN (Millipore,
Molshein, France, monoclonal 1:2000), nestin (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA, monoclonal 1:200), CD34 (Dako,
Glostrup, DK, monoclonal, 1:150), IDH-1 (Dianova, Hamburg,
Germany, monoclonal 1:50), HLA-DR (Dako, Glostrup, DK,
monoclonal, 1:400) and Ki67 (Dako, Glostrup, DK, monoclonal,
1:150).
2.7. Surgical outcome
Surgical outcome with regard to seizure control was deter-
mined at regular postoperative follow up assessments by CEP and
RPS. Surgical outcome was classiﬁed in four grades according to the
following criteria, which are largely based on Engel’s classiﬁca-
tion47: grade I, free of disabling seizures; grade II, almost seizure-
free (three or fewer diurnal or nocturnal seizures per year); grade
III, worthwhile improvement (but more than three diurnal or
nocturnal seizures per year); grade IV, no signiﬁcant improvement.
For analysis, favourable outcome was considered either as grade I,
or as grades I and II, as shown in the tables. Unless otherwise
speciﬁed, surgical outcome refers to the outcome during the
longest follow up available for each patient.
2.8. Statistical analysis
Univariate analysis: Two-tailed x2 testing with one degree of
freedom and with Yate’s correction was used to compare the
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groups of patients with normal/abnormal neuroimaging ﬁndings,
frontal/temporal resections and invasive/non-invasive recordings.
When there were expected frequencies below 5, two tailed Fisher’s
exact test was used. Existence of signiﬁcant differences was
assumed if at p < 0.05. Analysis was carried out with Graphpad
Software (www.graphpad.com/quickcalcs/contingency1.cfm). Con-
ﬁdence intervals for proportions in Tables 3 and 4 were calculated
according to Wilson procedure with a correction for continuity
(http://vassarstats.net/prop1.html).
Multivariate analysis: Multiple logistic regression and ANOVA
analyses were undertaken using SPSS for Windows version 15.
3. Results
3.1. Patients
Among the 243 patients who fulﬁlled the inclusion criteria, the
average age at operation was 35 years (range 3–74 years). The
average follow up period was 41.1 months (range 12–134 months).
Among the 243 patients, 233 had lobar or sub-lobar resections,
8 had multilobar resections and two had excision of hypothalamic
hamartoma.
Among the 233 patients with lobar or sub-lobar resections, 181
(78%) had temporal lobe resections, 41 (18%) had frontal lobe
resections, 3 (1%) had parietal lobe resections, and 8 (3%) had
occipital lobe resections. Table 1 shows the proportions of each
outcome grade among temporal and frontal resections. Among the
temporal resections, 158 were en-block temporal lobectomies and
23 were lesionectomies. Among the three patients who underwent
parietal resections, one enjoyed outcome grade I, and two had
outcome grade III. Among the 8 patients with occipital resections,
6 enjoyed outcome grade I, one had outcome III and one had
outcome IV.
The 8 patients who underwent multilobar resections included
5 patients with temporo-occipital resections and 3 patients with
fronto-parietal resections. Among the 8 patients, two had outcome
grade I, three had grade II, one patient had grade III and two had
grade IV.
Among the two patients who underwent excision of hypotha-
lamic hamartoma, one had outcome grade I and one had outcome
grade IV.Table 1
Number of patients with each outcome grade (I–IV) according to patient’s subpopulati
(seizure free) is entered in a separate column as this grade can be crucial for consider
Sub-population I Ia
Temporal resections 98 (54%) 84
Temporal lesionectomies 15 (65%) 13
Extratemporal resections 25 (48%) 21
Frontal resections 18 (44%) 15
Extrafrontal resections 105 (55%) 90
Normal MRI 14 (44%) 10
Lesional MRI 109 (54%) 95
Normal MRI in temporal resections 12 (52%) 8
Lesional MRI in temporal resections 86 (54%) 76
Normal MRI in frontal resections 2 (22%) 2
Lesional MRI in frontal resections 16 (50%) 13
Intracranial electrodes required 41 (48%) 32
No intracranial electrodes required 82 (56%) 73
Intracranial electrodes in extratemporal resections 9 (43%) 8
No intracranial electrodes in extrateporal resections 16 (52%) 13
Intracranial electrodes in temporal resections 32 (49%) 24
No intracranial electrodes in temporal resections 66 (57%) 60
Intracranial electrodes in frontal resections 6 (35%) 6
No intracranial electrodes in frontal resections 12 (50%) 93.2. Relation between outcome and preoperative factors
Among all 233 patients who underwent lobar or sub-lobar
resections, 123 (53%) enjoyed outcome grade I, 37 (16%) had grade
II, 50 (21%) had grade III and 23 (10%) had grade IV. Among the
123 patients with grade I, 105 enjoyed grade Ia (completely seizure
free). Table 1 shows the number and percentage of patients having
each outcome grade according to patient’s subpopulations.
Differences in the proportions of patients with grade I are minimal
if groups smaller than 20 patients are excluded.
Table 2 shows the 2 by 2 contingency tables corresponding to
the relation between surgical outcome and several univariate
factors. Analysis was carried out separately considering favourable
outcome as grade I, or as grades I plus II. When grouping favourable
outcome as grade I and poor outcome as grades II, III or IV, no
patient sub-population was associated with better or worse
outcome. When grouping favourable outcome as grades I or II
and poor outcome as III or IV, in the complete population there was
no difference in outcome between the patients who had
abnormalities on neuroimaging and those who did not, nor
between patients who required intracranial recordings and those
who did not. Temporal resections were associated with better
outcome than frontal resections. More speciﬁcally, the poorer
outcome shown by frontal resections was due to the frontal
patients with normal imaging, who did worse than either frontal
patients with lesions or temporal patients with or without lesions.
Among temporal resections, there was no difference in outcome
between patients with and without neuroimaging abnormalities.
Among patients with lesions on imaging, temporal and frontal
resections showed similar outcomes.
Forward and backward stepwise multivariate logistic regres-
sion was carried out with the following as independent covariates:
neuroimaging (normal versus abnormal), need for intracranial
recordings (yes/no), resection lobe (temporal versus others, and
frontal versus others) and neuropathology (mesial temporal
sclerosis versus others). None of the covariates were identiﬁed
as reliable predictors for the hypothesised model to ﬁt the data.
One-way ANOVA analysis showed no signiﬁcant association
between pathology type and surgical outcome.
Fig. 1 shows surgical outcome according to the duration of the
epilepsy at the time of surgery. The percentage of outcome grade I
is the highest for all durations. However, the percentages of poorer
outcome grades III and IV are lowest in patients operated within aons for all 233 patients who underwent lobar or sub-lobar resections. Subgrade Ia
ations regarding driving and withdrawal of medication.
 II III IV Total
 (46%) 33 (18%) 35 (19%) 15 (8%) 181
 (57%) 1 (4%) 5 (22%) 2 (9%) 23
 (40%) 4 (8%) 15 (29%) 8 (15%) 52
 (37%) 4 (10%) 12 (29%) 7 (17%) 41
 (47%) 33 (17%) 38 (20%) 16 (8%) 192
 (31%) 7 (22%) 7 (22%) 4 (13%) 32
 (47%) 30 (15%) 43 (21%) 19 (9%) 201
 (35%) 6 (26%) 4 (17%) 1 (4%) 23
 (48%) 27 (17%) 31 (20%) 14 (9%) 158
 (22%) 1 (11%) 3 (33%) 3 (33%) 9
 (41%) 3 (9%) 9 (28%) 4 (13%) 32
 (37%) 12 (14%) 25 (29%) 8 (9%) 86
 (50%) 25 (17%) 25 (17%) 15 (10%) 147
 (38%) 1 (5%) 7 (33%) 4 (19%) 21
 (42%) 3 (10%) 8 (26%) 4 (13%) 31
 (37%) 11 (17%) 18 (28%) 4 (6%) 65
 (53%) 22 (19%) 17 (15%) 11 (9%) 116
 (35%) 1 (6%) 6 (35%) 4 (24%) 17
 (38%) 3 (13%) 6 (25%) 3 (13%) 24
Table 2
Univariate analysis of prognostic factors for all 233 patients who underwent lobar or sub-lobar resections. Df = degrees of freedom; na = not applicable; x2 = two tailed Chi-
squared test with Yates correction; F = Fisher exact test; and *signiﬁcant difference.
Condition tested N Contingency table Statistic Df p
Grade I versus grades II + III + IV outcomes
Temporal vs. extratemporal resections 233 98, 83 vs. 25, 27 x2 = 0.378 1 0.5387
Temporal vs. frontal resections 222 98, 83 vs. 18, 23 x2 = 1.025 1 0.3114
Frontal vs. extrafrontal resections 233 18, 23 vs. 105, 87 x2 = 1.174 1 0.2786
Normal vs. lesional MRI 233 14, 18 vs. 109, 92 x2 = 0.832 1 0.3617
Normal vs. lesional MRI in temporal resections 181 12, 11 vs. 86, 72 x2 = 0.041 1 0.8392
Normal vs. lesional MRI in frontal resections 41 2, 7 vs. 16, 16 F = 0.2544 na 0.2544
Temporal vs. frontal in patients with lesional MRI 190 86, 72 vs. 16, 16 x2 = 0.07 1 0.79
Temporal vs. frontal in patients with normal MRI 32 12, 11 vs. 2,7 F = 0.235 na 0.235
Need vs. no need for intracranial electrodes 233 41, 45 vs. 82, 65 x2 = 1.124 1 0.2890
Need vs. no need for intracranial electrodes in extra-temporal resections 52 9,12 vs. 16, 15 x2 = 0.114 1 0.7359
Need vs. no need for intracranial electrodes in temporal resections 181 32, 33 vs. 66, 50 x2 = 0.701 1 0.4023
Need vs. no need for intracranial electrodes in frontal resections 41 6, 11 vs. 12, 12 x2 = 0.379 1 0.5383
Grades I + II versus grades III + IV outcomes
Temporal vs. extratemporal resections 233 131, 50 vs. 29, 23 x2 = 4.435 1 0.0352*
Temporal vs. frontal resections 222 131, 50 vs. 22, 19 x2 = 4.628 1 0.0315*
Frontal vs. extrafrontal resections 233 22, 19 vs. 138, 54 x2 = 4.399 1 0.0360*
Normal vs. lesional MRI 233 21, 11 vs. 139, 62 x2 = 0.038 1 0.8457
Normal vs. lesional MRI in temporal resections 181 18, 5 vs. 113, 45 x2 = 0.182 1 0.6701
Normal vs. lesional MRI in frontal resections 41 3, 6 vs. 19, 13 F = 0.2595 na 0.2595
Temporal vs. frontal in patients with lesional MRI 190 113, 45 vs. 19,13 x2 = 1.322 1 0.25
Temporal vs. frontal in patients with normal MRI 32 18, 5 vs. 3,6 F = 0.035 na 0.035*
Need vs. no need for intracranial electrodes 233 53, 33 vs. 107, 40 x2 = 2.644 1 0.1039
Need vs. no need for intracranial electrodes in extra-temporal resections 52 10, 11 vs. 19, 12 x2 = 0.475 1 0.4906
Need vs. no need for intracranial electrodes in temporal resections 181 43, 22 vs. 88, 28 x2 = 1.508 1 0.2194
Need vs. no need for intracranial electrodes in frontal resections 41 7, 10 vs. 15, 9 x2 = 1.063 1 0.3025
Examples on how to read this table:
The ﬁrst row means that among patients undergoing temporal resections, 98 had grade I and 83 had grades II, III or IV, whereas among extratemporal resections,
25 had grade I and 27 had grades II, III or IV. The difference between these proportions is not statistically signiﬁcant (p = 0.5387).
Row 14 means that among patients undergoing temporal resections, 131 had grade I or II and 50 had grade III or IV, whereas among frontal resections, 22 had grade I or II and
19 had grade III or IV. The difference between these proportions is statistically signiﬁcant (p = 0.0315), suggesting that temporal resections are associated with better
outcome than frontal resection.
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percentages of poor outcome grades increase with years, until
there is a moderate decrease for the longest durations.
3.3. Outcome according to individual proﬁle
Tables 3 and 4 show the proportions of patients who enjoyed
favourable outcome for each combination of the following factors:
presence of neuroimaging abnormalities, use of intracranial
recordings, resection lobe and pathology. Favourable outcomeFig. 1. Surgical outcome according to duration of the epilepsy at the time of surgery. The h
vertical outcome represents the percentage of each outcome grade.was considered as grade I for Table 3 and as grades I or II for Table 4.
The number of patients with parietal or occipital resections are
small, but are nevertheless included for completeness. Speciﬁc
combinations of the above factors yielded a wide range of
probability of success. The clinician can use these tables to advise
individual patients on likelihood of success. For instance, if the
patient has normal MRI and a temporal resection is contemplated,
he/she could expect a 52% chance of becoming free of disabling
seizures (estimated from a sample of 23 patients, Table 3). However,
if having 3 or less disabling seizures per year is acceptable, then theorizontal axis represents the duration of epilepsy at the time of surgery in years. The
Table 3
Proportion of patients undergoing resective surgery, with Engel outcomes I (free of disabling seizures) under each condition for all 233 patients who underwent lobar or sub-
lobar resections. All patient with normal MRI underwent intracranial recordings. Patients with multilobar resections are excluded. IC = intracranial recordings; NP = no
patients; NA = not applicable; MTS = mesial temporal sclerosis; AVM = arteriovenous malformation; DNET = dysembryoplastic neuroepithelial tumour; FDC = focal cortical
dysplasia; NS = non-speciﬁc; Other = encephalitis (1 patient) and scar (1 patient); and CI = 95% conﬁdence interval (calculated for groups with 10 or more patients). For groups
with less than 10 patients, conﬁdence intervals are wide and the small sample may provide an unreliable estimate of prognosis.
Temporal Frontal Parietal Occipital Total
According to MRI ﬁndings and use of IC
Normal MRI with IC 52% (12/23)
CI = 31–73%
22% (2/9) NP NP 44% (14/32)
CI = 27–62%




0% (0/1) 100% (4/6) 56% (82/147)
CI = 47–64%
Lesional MRI with IC 48% (20/42)
CI = 32–63%
50% (4/8) 50% (1/2) 100% (1/2) 48% (26/54)
CI = 34–62%
According to pathology
MTS only (total) 51% (49/96)
CI = 41–61%
NA NA NA 51% (49/96)
CI = 41–61%
MTS + normal MRI + IC 42% (5/12)
CI = 17–71%
NA NA NA 42% (5/12)
CI = 17–71%
MTS seen on MRI + no IC 48% (30/63)
CI = 35–60%
NA NA NA 48% (30/63)
CI = 35–60%
MTS seen on MRI + IC 67% (14/21)
CI = 43–85%
NA NA NA 67% (14/21)
CI = 43–85%
MTS + other lesion 60% (6/10)
CI = 27–86%
NA NA NA 60% (6/10)
CI = 27–86%
AVM or cavernoma 55% (6/11)
CI = 25–82%






0% (0/1) 100% (2/2) 52% (26/50)
CI = 38–66%
DNET 88% (7/8) NP NP 67% (2/3) 82% (9/11)
CI = 48–97%
FCD (total) 33% (1/3) 70% (7/10)
CI = 35–92%
50% (1/2) 67% (2/3) 61% (11/18)
CI = 36–82%
FCD + normal MRI + IC NP 75% (3/4) NP NP 75% (3/4)
FCD seen on MRI + no IC 100% (1/1) 100% (3/3) NP 100% (1/2) 83% (5/6)
FCD seen on MRI + IC 0% (0/2) 67% (2/3) 50% (1/2) (1/1) 50% (4/8)
Cyst NP 100% (1/1) NP NP 100% (1/1)
NS 50% (9/18)
CI = 27–73%
0% (0/6) NP NP 38% (9/24)
CI = 20–59%
Infarct 67% (2/3) 0% (0/1) NP NP 50% (2/4)
Other NP 50% (1/2) NP NP 50% (1/2)
Total patients 54% (98/181) CI = 47–62% 44% (18/41)
CI = 29–60%
33% (1/3) 75% (6/8) 53% (123/233)
CI = 46–59%
Examples on how to read this table:
a) If a patient has a lesion on MRI and a temporal resection is contemplated without the need for intracranial recordings, there is a 57% chance of becoming free of disabling
seizures (estimated in 116 patients, with a 95% conﬁdence interval of 47–66%).
b) If a patient has a frontal lesion on MRI that can be resected without the need of intracranial electrodes, there is a 50% chance of becoming free of disabling seizures
(estimated in 24 patients, with a 95% conﬁdence interval of 30–70%).
A. Kumar et al. / Seizure 22 (2013) 818–826 823chance of success increases to 78% (Table 4). If the patient is
contemplating surgery to become seizure free with the purpose of
driving, then the probability of success is 35% (grade Ia in Table 1).
3.4. Outcome and duration of follow-up in unilobar resections
At 12 months, 62% had grade I and 51.2% had grade Ia (data
available from 205 patients). At 24 months, 57.5% had grade I and
48.9% had enjoyed Ia (data available from 188 patients). At 36
months, 57% had grade I and 45.6% had grade Ia (data available
from 149 patients). Among the 127 patients with follow up longer
than 36 months, 53.5% had grade I and 41.7% enjoyed grade Ia.
Consequently, there was a moderate worsening of grade I outcome
with time after surgery of around 8–9%.
4. Discussion
We have studied presurgical prognostic factors in a large series
of patients undergoing resective surgery for the treatment of
epilepsy over 12 years at King’s College Hospital. Our series
contains a heterogeneous population that includes several
subgroups with high patient numbers, providing outcome
estimates for speciﬁc patient’s subpopulations. Essentially, ourresults suggest that outcome after temporal and occipital
resections is better than after frontal procedures. In the overall
population, the presence of neuroimaging abnormalities and the
need for intracranial recordings did not affect outcome. Patients
undergoing temporal resections showed better outcome than
those with frontal resections, due to the poor outcome seen in
frontal patients with normal neuroimaging. Among temporal
resections, there was no difference in outcome between patients
with and without neuroimaging abnormalities. Among patients
with lesions on imaging, temporal and frontal resections showed
similar outcomes. In sub-groups with 10 or more frontal patients,
between 33% and 80% have favourable outcome (Table 4);
suggesting that even in the worse circumstances, the overall
outcome can be good. The differences found were not sufﬁciently
strong to appear as reliable predictors after multiple logistic
regression, which highlights the difﬁculties underlying presurgical
prediction of surgical outcome. The clinician can use the provided
tables in this article to advise individual patients on likelihood of
success. In addition, the proportion of good outcome was highest in
patients operated within a year of their epilepsy starting. There
was a moderate worsening of outcome (8–9%) with time after
surgery, which should be taken into consideration when inter-
preting the results.
Table 4
Proportion of patients undergoing resective surgery, with Engel outcomes I or II (seizure free or rare seizures) under each condition for all 233 patients who underwent lobar
or sub-lobar resections. All patients with normal MRI underwent intracranial recordings. Patients with multilobar resections are excluded. IC = intracranial recordings;
NP = no patients; NA = not applicable; MTS = mesial temporal sclerosis; AVM = arteriovenous malformation; DNET = dysembryoplastic neuroepithelial tumour; FDC = focal
cortical dysplasia; NS = non-speciﬁc; Other = encephalitis (1 patient) and scar (1 patient); and CI = 95% conﬁdence interval (calculated for groups with 10 or more patients). For
groups with less than 10 patients, conﬁdence intervals are wide and the small sample may provide an unreliable estimate of prognosis.
Temporal Frontal Parietal Occipital Total
According to MRI ﬁndings and use of IC
Normal MRI with IC 78% (18/23)
CI = 56–92%
33% (3/9) NP NP 66% (21/32)
CI = 47–81%




0% (0/1) 67% (4/6) 73% (107/147)
CI = 65–80%
Lesional MRI with IC 60% (25/42)
CI = 43–74%
50% (4/8) 50% (1/2) 50% (1/2) 57% (31/54)
CI = 43–71%
According to pathology
MTS only (total) 73% (70/96)
CI = 63–81%
NA NA NA 73% (70/96)
CI = 63–81%
MTS + Normal MRI + IC 75% (9/12)
CI = 43–93%
NA NA NA 75% (9/12)
CI = 43–93%
MTS seen on MRI + no IC 73% (46/63)
CI = 60–83%
NA NA NA 73% (46/63)
CI = 60–83%
MTS seen on MRI + IC 71% (15/21)
CI = 48–88%
NA NA NA 71% (15/21)
CI = 48–88%
MTS + other lesion 80% (8/10)
CI = 44–96%
NA NA NA 80% (8/10)
CI = 44–96%
AVM or cavernoma 73% (8/11)
CI = 39–93%






0% (0/1) 100% (2/2) 64% (32/50)
CI = 49–77%
DNET 100% (8/8) NP NP 67% (2/3) 91% (10/11)
CI = 57–100%
FCD (total) 33% (1/3) 80% (8/10)
CI = 44–96%
50% (1/2) 67% (2/3) 67% (12/18)
CI = 41–86%
FCD + normal MRI + IC NP 100% (4/4) NP NP 100% (4/4)
FCD seen on MRI + no IC 100% (1/1) 100% (3/3) NP 50% (1/2) 83% (5/6)
FCD seen on MRI + IC 0% (0/2) 67% (2/3) 50% (1/2) (1/1) 50% (4/8)
Cyst NP 100% (1/1) NP NP 100% (1/1)
NS 72% (13/18)
CI = 46–89%
0% (0/6) NP NP 54% (13/24)
CI = 33–74%
Infarct 67% (2/3) 0% (0/1) NP NP 50% (2/4)
Other NP 50% (1/2) NP NP 50% (1/2)




33% (1/3) 75% (6/8) 69% (160/233)
CI = 62–74%
Examples on how to read this table:
a) If a patient has a lesion on MRI and a temporal resection is contemplated after having had intracranial recordings, there is a 60% chance of improving by suffering 3 or less
disabling seizures per year (estimated in 42 patients, with a 95% conﬁdence interval of 43–74%).
b) If a patient shows mesial temporal sclerosis on MRI and a temporal lobectomy is contemplated without the need for intracranial recordings, there is a 73% chance of
improving by suffering 3 or less disabling seizures per year (estimated in 63 patients, with a 95% conﬁdence interval of 60–83%).
A. Kumar et al. / Seizure 22 (2013) 818–826824The prognostic value of neuroimaging is controversial, with
different studies reporting contradictory results. Whereas in some
series, normal neuroimaging did not affect prognosis in the general
population of operated patients,9,39 presence of MRI abnormalities
has been reported as a positive prognostic sign in a large meta-
analysis series,25 in temporal14,26 and in frontal11 lobe epilepsies.
In the present series, we have found that the presence of MRI
abnormalities does not affect outcome in the overall population
but frontal patients with normal imaging showed worse outcome
than lesional frontal patients or than temporal patients with or
without normal imaging. In any case, among the largest sub-group
of temporal lobe patients, the absence of MRI abnormalities is
clearly not associated with poorer outcome. This is in agreement
with a large Japanese series, which found normal neuroimaging to
be a negative prognostic sign in extratemporal but not in temporal
lobe epilepsy.48
In our series, frontal lobe resections showed worse outcome
than resections at other sites (largely temporal). The worse
outcome of frontal compared to temporal resections is well
established. However, in our series this difference was due to the
lower proportion of favourable outcome found among frontal
patients with normal MRI (Tables 3 and 4). Outcome in normal
imaging frontal patients was worse than either frontal patientswith lesions or temporal patients with or without lesions.
Surprisingly, among patients with lesions there was no difference
between frontal and temporal resections, which somehow
challenges the standard view that frontal resections necessarily
do worse than temporal. In the absence of a lesion, the better
outcome observed among temporal patients may derive from the
fact that 80% of temporal lobe epilepsies arise from the
hippocampal formation and surrounding medial temporal struc-
tures.49 This implies that removing the hippocampus and
surrounding tissue would beneﬁt a high proportion of temporal
patients. By contrast, the frontal lobes are much larger and do not
have an equivalent a priori likely anatomical candidate to guide the
resection. Accordingly, previous series have identiﬁed temporal
lobectomy34 and mesial temporal sclerosis24,25 as favourable
prognostic signs.
The use of intracranial recordings has been reported as a
negative prognostic sign in the general population of operated
patients,24,25 in patients with focal cortical dysplasia50 and in
those with frontal epilepsy.37 In contrast, we have not observed
that the use of intracranial electrodes is associated with worse
post-surgical seizure control. This might have been unexpected,
since patients undergoing intracranial recordings are the most
difﬁcult group to assess. However, among the patients assessed
A. Kumar et al. / Seizure 22 (2013) 818–826 825with intracranial electrodes, surgery was pursued only in those
patients fulﬁlling stricter criteria with regard to seizure onset,
which could explain the favourable results obtained in this
population.
It may be surprising that the outstanding advances on
neuroimaging and electroencephalography during the last two
decades have not been associated with similar improvements in
our ability to predict surgical outcome (other than normal imaging
frontal resections vs. temporal or lesional frontal resections). Such
advances have been associated with a considerable increment in
the number patients where surgery is performed, including more
difﬁcult patients where surgery would not have been contemplat-
ed a few years ago. However, among those patients were surgery
is ultimately performed, outcome is still notoriously difﬁcult to
predict.
Although the presence of negative prognostic factors tends to
associate with poor outcome, favourable outcome can clearly occur
in the presence of such factors. Consequently, in addition to the
investigation of prognostic factors, we offer tabulations of
empirical estimates of patients with favourable outcome according
to speciﬁc combinations of circumstances. In some conditions, the
numbers are small for statistical robustness (e.g., parietal and
occipital resections). However, due to the large number of patients
studied, in many cases (particularly in temporal and frontal
resections) the number of patients is sufﬁcient for empirical
estimation, even after splitting the population into multiple
combinations of circumstances. This novel but simple approach
may be more helpful in advising individual patients than the study
of prognostic factors, because patients tend to be interested in their
likelihood of success under their speciﬁc circumstances rather than
on whether they would do better under different conditions.
Table 1 includes the likelihood to become seizure free, which can
be relevant when contemplating medication withdrawal and
driving. For classiﬁcation of the nature of lesions in Tables 3 and 4,
pathological ﬁndings on the resected specimens were used for sake
of accuracy. Although strictly speaking pathology is a postsurgical
ﬁnding, in most cases the broad groups in which pathological
ﬁndings were divided could be identiﬁed presurgically. In such
cases, the nature of the underlying lesion becomes a useful
prognostic criterion to discuss during presurgical assessment. For
groups with less than 10 patients, conﬁdence intervals are wide
and the small sample may provide an unreliable estimate of
prognosis.
5. Conclusion
Overall, nearly 70% of patients undergoing resective surgery
enjoy favourable post-surgical seizure control. Normal neuroim-
aging should not discourage surgery in temporal lobe epilepsy but
is a negative prognostic sign in frontal lobe epilepsy. Among
patients with imaging lesions, there is no difference in outcome
among temporal and frontal patients. Likelihood of favourable
outcome under the patient’s individual circumstances is estimated
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